Michael Milken’s Prostate Cancer Foundation’s $50M Program for Precision Cancer Research is Saving Lives

Nov 13, 2019 | Oncology, Prostate Cancer, VA, Veterans

Myovant Reports Results from Phase 3 HERO Trial of Relugolix for Prostate Cancer; NDA Filing Planned in 2020

Four new Prostate Cancer Foundation (PCF) Centers of Excellence (COEs) have joined PCF’s dedicated network of centers executing the ambitious mission of improving the care for U.S. Veterans with prostate cancer. PCF now has 10 COEs to date distributed across America.


The PCF COEs include:

Philadelphia, PA; Washington, DC; Durham, NC; Tampa Bay, FL; Seattle WA; Chicago, IL; Bronx, NY; Los Angeles, CA; Manhattan, NY; and Ann Arbor, MI,

Prostate Cancer Diagnosis among VA Population

More than 15,000 men are diagnosed in the Veterans Affairs (VA) with prostate cancer annually making it the most frequently diagnosed cancer among veterans. The numbers are higher for African American males.

A $50M Initiative includes Clinical Trials Access

Back in 2016 the PCF Veterans Health Initiative was launched with a $50 million infusion to deliver innovative, best-in-class prostate cancer care to Veterans, which includes expanding genomic data banking to provide improved prostate cancer treatment, greater access to clinical trials and resources to develop improved precision oncology care.

Move to Precision Care

Precision medicine is individualized, offering custom-tailored treatment that targets cancer by its genetic signature. PCF positions that it is a key to ending deaths from prostate cancer. More than half the funds the  PCF has committed has been used to launch 10 COEs in a collaborative network at the forefront of precision oncology for prostate cancer.

A Patient’s Story

Chris Seelye, U.S. Navy Veteran and patient at the Puget Sound VA in Seattle, WA noted, “I was diagnosed five and a half years ago with a particularly lethal form of prostate cancer that had metastasized.” He continued, “I was fortunate to be treated at a PCF COE where it was discovered through genetic testing that the BRCA gene was implicated in my cancer. I was given a precise form of treatment specific to my cancer that literally saved my life. It is critical that all men, including Veterans understand their risks.” See more about Seelye at the PCF YouTube channel

About PCF

The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving cancer research. Founded in 1993 by Mike Milken, the PCF has raised more than $800 million in support of cutting-edge research by more than 2,200 research projects at 220 leading cancer centers in 22 countries around the world. Thanks in part to the PCF’s commitment to ending death and suffering from prostate cancer, the death rate is down more than 50% and countless more men are alive today as a result. The PCF research now impacts more than 70 forms of human cancer by focusing on immunotherapy, the microbiome, and food as medicine. Learn more at their website.

Call to Action: Interested in learning more about clinical trials offered by PCF-VA COE? Veterans can call 206-277-3621 or visit here.